ReadYourDNA

Diabetes Drugs (class)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Diabetes Drugs

What it is

Diabetes medicines lower blood sugar in different ways: insulin and its analogues replace or add to the body's own insulin; metformin reduces glucose release from the liver; sulfonylureas make the pancreas release more insulin; DPP-4 inhibitors and GLP-1 agonists work through gut hormones; SGLT2 inhibitors let the kidneys pass excess sugar; and glitazones improve insulin sensitivity. This page collects studies on diabetes medicines as a group.

How genes come into it

The gene studies listed for the group looked at IRS1, a gene of insulin signalling, for blood sugar response. The gene findings for individual medicine groups, such as SLC22A1 for metformin or CYP2C9 for sulfonylureas, are on their own pages. A notable case is monogenic diabetes: people with HNF1A variants (MODY) often respond unusually well to sulfonylureas. There is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Diabetes Drugs. Upload your DNA file to see which of these rows apply to you.

Rated evidence (1 rated variant)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

IRS1 rs1801278: Level 3. Efficacy: Diabetes Mellitus, Type 2. 1.

Response (3 findings)

Studies of how well it worked in people carrying a variant.

IRS1 rs1801278: Genotypes CT + TT is associated with decreased response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to genotype CC.

IRS1 rs2943641: Allele T is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele C.

IRS1 rs7578326: Allele G is not associated with response to Drugs Used In Diabetes in people with Diabetes Mellitus, Type 2 as compared to allele A.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Actos (Thiazolidinediones)

Amaryl (Sulfonylureas)

Antithyroid Drugs (class) (Antithyroid Agents)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com